News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, November 5, 2018

OK-INBRE Research Project Investigator (RPI) Program

Proposal deadline: February 22, 2019

Call for proposals:

https://okinbre.ouhsc.edu/Funding-Opportunities/Funding-Opportunities-for-OUHSC-and-OMRF

The Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) is requesting

applications for Research Project Investigator Awards (RPI).  The program seeks to support

proposals designed to generate preliminary data that enhances the competitiveness of the

OUHSC/OMRF investigators for future extramural funding.  The proposed project must align

with one of the biomedical research themes of the OK-INBRE program: Cancer, Developmental

Biology or Infectious Diseases.  The RPI project period is 2 ½ years in duration funded at

$100,000 in direct costs per year.  Selected projects will commence in May 2019.

 

 

DOE Scholars Program - The DOE Scholars Program introduces students and recent

college graduates to the U.S. Department of Energy (DOE) mission and operations.

Why should I apply?

Being selected as a DOE Scholar offers the following benefits:

  • Stipends starting at $600 per week for undergraduates and $650 per week for graduate students

post graduates during the internship period

  • Limited travel reimbursement to/from assigned location
  • Direct exposure to and participation in projects and activities in DOE mission-relevant research areas
  • Identification of career goals and opportunities
  • Development of professional networks with leading scientists and subject matter experts

Eligibility

  • Be a U.S. citizenship
  • Be an undergraduate, graduate student, or recent graduate of an accredited institution of higher

education majoring in science, technology, engineering, mathematics, and related areas.

  • Must be pursuing a degree or have received a degree within 5 years of their starting date in a

science, technology, engineering or mathematics (STEM) discipline or have demonstrated

interest or experience in a STEM field that supports the DOE mission. 

Veterans are encouraged to apply.  DOE Scholars selected by the Federal Energy Management Program (FEMP) 

are given a Veteran's Preference. Selected veterans will be placed at various federal agencies in Washington, D.C.

Veteran candidates who have received a college degree in an appropriate science, technology, engineering or

math discipline within ten years of their starting date are eligible for appointments.

How to Apply

Applications and supporting materials must be submitted at

https://www.zintellect.com/Opportunity/Details/DOE-Scholars-2019

Application deadline: December 17, 2018, 5:00 PM EST

For more information: Visit https://orise.orau.gov/doescholars

Questions? doescholars@orau.org

Please share this information with friends and colleagues who might be interested in opportunities with DOE.

DOE has partnered with the Oak Ridge Institute for Science and Education (ORISE) to manage this program

 

 

Questions about your VA appointment and externally funded research?  Forms, information,

and FAQs can be found here:

https://research.ouhsc.edu/Research-Administration/Policies/VA-Joint-Appointments

 

 

OUHSC will Celebrate Corporate Compliance and Ethics Week

Monday, November 5, 2018 through Friday, November 9, 2018.  There will be different activities related

to Compliance and Ethics each day.     Each day of Corporate Compliance and Ethics Week, you will

receive an email from Compliance to share news and ideas, and to announce the schedule of events

for the day.  Please see the attachment for more complete information.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Compliance and Ethics Week.pdf?ver=2018-10-22-073454-467

 

2019 Annual Cancer Research Symposium | Registration & Call for Abstracts

Abstracts due Friday, November 16, 2018.  Conference is Friday, February 1, 2019. 

See attached document for additional information.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Cancer Research Symposium.docx?ver=2018-10-08-074829-697

 

ORAU-Directed Research and Development (ODRD) Program

The FY 2019 competition for collaborative awards of up to $75,000 to be shared between the university

and ORAU researchers is now open. We anticipate and expect that these seed funds will position the

collaborative teams to be more competitive for new, external funding opportunities. The deadline for

joint ORAU/university proposals is March 25, 2019 and potential university partners are encouraged

to submit concepts for discussion with ORAU partners as soon as possible. 

https://www.orau.org/university-partnerships/member-grant-programs/odrd.html

 

 

PHF Bridge Grant PROGRAM

Proposal Deadline: Friday, November 16, 2018

The primary objective of the PHF Bridge Grant program is to provide funding of limited duration to

enhance OUHSC faculty competitiveness for NIH R01 and Department of Defense (DoD) extramural

funding.  PHF Bridge Grant funding is specifically for those OUHSC faculty members who have

submitted R01 applications to NIH or applications to DoD that have been reviewed and scored,

but not funded.   Applicants may request support of up to $75,000 for one year.

Guidelines and Application Form is attached or go to:

https://research.ouhsc.edu/News/TabId/9629/ArtMID/25795/ArticleID/8107/PHF-Bridge-Grant-Program-Fall-2018.aspx.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF-Bridge Grant-Guidelines - Revised - October 2018.docx?ver=2018-11-05-072601-243

 

END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer Conference

Dates: December 6-7, 2018

Location: Samis Education Center

Registration and Call for Abstracts: http://end2cancer.com/

Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude

in the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in

the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis,

imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by

eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating

nanomedicine from bench-to-bedside.

Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery and

applications, biological and non-biological systems as carriers and therapeutics, molecular imaging,

biomimetics, immune-oncology, toxicology and clinical trials.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers,

physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business

professionals, educators and technology transfer specialists. Students and fellows will have an opportunity

to present their work as a poster presentation and compete for awards.

 

 

NIH NOTICES

 

Reminder: NIH Natural Disaster Policy - Hurricane Michael (NOT-OD-19-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-018.html

 

Publication of the Revised NIH Grants Policy Statement (Rev. October 2018) for FY 2019

(NOT-OD-19-021)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-021.html

 

Notice of Information: Re-Opening the Comment Period for an NIH Proposal to Amend the NIH

Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline

Oversight of Human Gene Transfer Protocols (NOT-OD-19-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-022.html

 

Notice of Intent to Publish Parent Funding Opportunity Announcements for Basic Experimental

Studies with Humans (NOT-OD-19-024)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-024.html

 

Notice of Participation of the National Institute on Aging (NIA) in PAR-18-714, "Academic Research

Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"

(NOT-AG-18-036)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-036.html

 

Pre-Solicitation Notice: Simian Vaccine Evaluation Units (SVEUs) (NOT-AI-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-007.html

 

Notice of NCCIH Participation in PAR-18-714, "Academic Research Enhancement Award for

Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)" (NOT-AT-19-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-010.html

 

Pre-Solicitation Notice: Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical

Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"

(NOT-CA-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-004.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology

Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

(NOT-CA-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-005.html

 

Notice for a Pre-Application Webinar for Biospecimen Funding Opportunity Announcement

PAR-18-947 (U01) (NOT-CA-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-006.html

 

Notice of NIDA's Participation in PAR-18-836 "Global Brain and Nervous System Disorders Research

Across the Lifespan (R21 Clinical Trial Optional)" (NOT-DA-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-004.html

 

Notice of NIDA's Participation in PAR-18-835 "Global Brain and Nervous System Disorders Research

Across the Lifespan (R01 Clinical Trial Optional)" (NOT-DA-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-005.html

 

Notice of NIDCD Participation in PAR-18-714-Academic Research Enhancement Award for

Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) (NOT-DC-19-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-DC-19-001.html

 

Notice of Clarification of Award Budget for PAR-18-656 NIDCR Behavioral and Social Intervention

Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

(NOT-DE-18-023)
https://grants.nih.gov/grants/guide/notice-files/NOT-DE-18-023.html

 

NIDDK Targeted SBIR Funding Opportunity Announcements Modified to Allow SBIR Direct-to-Phase

II Applications (NOT-DK-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-19-003.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Development of Translational

Devices to Treat Pain (U18 Clinical Trial Not Allowed) (NOT-EB-18-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-18-030.html

 

Notice Announcing NIEHS Use of RFA-ES-16-005 "Mechanism for Time-Sensitive Research

Opportunities in Environmental Health Sciences (R21)" for Hurricanes Florence and Michael

Response Research (NOT-ES-19-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-19-001.html

 

Notice Announcing NIEHS Use PA-18-591 "Administrative Supplements to Existing NIH Grants

and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)" for Hurricane Florence

Research Response (NOT-ES-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-19-002.html

 

Notice Announcing NIEHS Use of PA-18-935 "Urgent Competitive Revision to Existing NIH Grants

and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" for Hurricanes Florence

and Michael Research Response (NOT-ES-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-19-003.html

 

Changes in NIGMS Support of Integrated Predoctoral Dual-degree M.D.-Ph.D. Training through the

Medical Scientist Training Program (NOT-GM-18-047)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-18-047.html

 

Notice of NIGMS Participation in PA-19-029 Innovation Corps (I-Corps) at NIH Program for NIH and

CDC Translational Research (Admin Supp Clinical Trial Not Allowed) (NOT-GM-19-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-001.html

 

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIGMS SBIR

FOAs (NOT-GM-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-003.html

 

Notice to Clarify the Participation of Foreign Scientists in PAR-17-340 "Collaborative Program Grant

for Multidisciplinary Teams (RM1)" (NOT-GM-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-004.html

 

NICHD Policy on Monitoring and Oversight of Clinical Trials (NOT-HD-18-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-020.html  

 

Notice of Pre-Application Technical Assistance Webinar for RFA-HD-19-022, Reproductive Medicine

Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required) (NOT-HD-18-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-022.html  

 

Notice Inviting the Community to Contribute to the Generation of NHGRI's '2020 Vision for Genomics'

(NOT-HG-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-005.html

 

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NHGRI Associated

SBIR FOAs (NOT-HG-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-006.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Human Genome Reference Center

(HGRC) (U41 Clinical Trial Not Allowed) (NOT-HG-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-007.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for High Quality Human Reference

Genomes (HQRG) (UM1 Clinical Trial Not Allowed) (NOT-HG-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-008.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Research and Development for

Genome Reference Representations (GRR) (U01, Clinical Trial Not Allowed) (NOT-HG-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-009.html

 

Notice of NHLBI Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and

CDC Translational Research (Admin Supp Clinical Trial Not Allowed) issued by the National Institutes

of Health (NOT-HL-18-658)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-658.html

 

Request for Information (RFI): Soliciting input for future research at the NHLBI regarding Late

complications after allogeneic hematopoietic stem cell transplantation or autologous gene modified

stem cell transplant for non-malignant blood disorders (NOT-HL-18-659)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-659.html

 

Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in

Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders (NOT-HL-18-660)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-660.html

 

Notice of Change to Funding Opportunity Announcement, RFA-MD-18-012 Research Centers in

Minority Institutions (RCMI) (U54 Clinical Trials Optional)" Regarding Late Applications (NOT-MD-18-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-18-019.html  

 

Notice of Information: NIMHs Interest in Areas of Stress Biology Research (NOT-MH-18-058)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-058.html

 

Notice to Extend PAR-18-941 Neuromodulation/Neurostimulation Device Development for Mental

Health Applications (R21 Clinical Trial Optional) (NOT-MH-18-060)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-060.html

 

Notice to Extend PAR-18-942 Neuromodulation/Neurostimulation Device Development for Mental

Health Applications (R01 Clinical Trial Optional) (NOT-MH-18-061)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-061.html

 

Request for Information (RFI): Guidance on Current Clinical Experience with the Use of Ketamine

for Suicide Prevention (NOT-MH-18-068)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-068.html

Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to

Treat Pain (UG3/UH3 Clinical Trial Optional) (NOT-NS-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-009.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to

Treat Pain (U44 Clinical Trial Optional) (NOT-NS-19-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-010.html

 

Notice of Change to Application Due Date for Administrative Supplement for the NINDS Research

Education Program for Residents and Fellow in Neurosurgery, Neuropathology, Neuroradiology and

Emergency Medicine (Admin Supplement) (NOT-NS-19-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-013.html

 

Notice of Correction to Revise Application Due Dates for PAR-18-910 Limited Competition for

NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial

Required) (NOT-TR-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-19-008.html

 

Notice of Correction to Revise Application Due Dates for NOT-TR-19-001 Notice of Availability of

Administrative Supplements for Microphysiological Systems Developers: Development of Tissue

Chips to Model Nociception, Opioid Addiction and Overdose (NOT-TR-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-19-009.html

 

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program

(NOT-TW-18-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-TW-18-005.html

 

Notice of Change in Application Due Date for PAR-17-001 "Emerging Global Leader Award (K43)"

(NOT-TW-18-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-TW-18-006.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular

Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed) (RFA-AG-19-025)

Deadline March 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-025.html

 

Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular

Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed) (RFA-AG-19-026)

Deadline March 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-026.html

 

A Census of Cells and Circuits in the Aging Brain (R01 Clinical Trial Not Allowed) (RFA-AG-19-027)

Deadline March 8, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-027.html

 

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) (RFA-FD-20-001)

Deadline June 25, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-001.html  

Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)

(RFA-HD-19-022) – Deadline January 18, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-022.html

 

Early Screening for Autism Spectrum Disorder (R01 Clinical Trial Not Allowed) (RFA-MH-19-120)

Deadline February 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-120.html

 

Early Screening for Autism Spectrum Disorder (R21 Clinical Trial Not Allowed) (RFA-MH-19-121)

Deadline February 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-121.html

 

NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50 Clinical Trial

Optional) (RFA-NS-18-026) – Deadline January 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-026.html

 

NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical Trial

Optional) (RFA-NS-18-027) – Deadline January 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-027.html

 

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination

(U24 Clinical Trial Not Allowed) (RFA-NS-19-006) – Deadline January 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-006.html

 

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG)

(R41/R42 Clinical Trial Not Allowed) (PA-19-033) – Deadline January 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-033.html

 

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG)

(R43/R44 Clinical Trial Not Allowed) (PA-19-034) – Deadline January 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-034.html

 

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community

Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl

Clinical Trial Not Allowed) (PA-19-035) – Deadline December 15, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-19-035.html

 

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (PAR-19-032)

Deadline February 26, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-032.html

 

Medical Scientist Training Program (T32) (PAR-19-036) – Deadline January 25, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-036.html

 

Initiative for Maximizing Student Development (IMSD) (T32) (PAR-19-037) – Deadline February 22, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-037.html

 

Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-19-038)

Deadline November 28, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-19-038.html

 

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead

Compounds (U01 Clinical Trial Not Allowed) (PAR-19-039) – Deadline September 10, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-039.html  

 

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead

Compounds (U01 Clinical Trial Optional) (PAR-19-040) – Deadline September 10, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-040.html

 

 

New Clinical Study Opportunities

***************************************************

Please note this is NOT a solicitation for study subjects

***************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:

  • Subjects With Locally Advanced Pancreatic Adenocarcinoma Which Is Unresectable
  • Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
  • Radius Breast Cancer Elacestrant ER+/HER2-Breat Cancer, Phase III
  • Head And Neck Squamous Cell Carcinoma
  • Phase III Program treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure
  • Phase 2a Study In Patients With Igan

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of these studies.

The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.

 

Print

x